Article Text

Download PDFPDF
Report From the 20th Meeting of the European Society of Gynaecological Oncology (ESGO 2017)
  1. Kamil Zalewski, MD*,,
  2. Elisa Piovano, MD, PhD,§,
  3. Zoia Razumova, MD,
  4. Ilker Selcuk, MD, PhD and
  5. Tanja Nikolova, MD, PhD#
  1. * Department of Gynaecologic Oncology, Holycross Cancer Center, Kielce;
  2. Department of Molecular and Translational Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland;
  3. Department of Surgical Sciences, University of Turin;
  4. § Obstetrics and Gynaecology Unit, Martini Hospital, Italy;
  5. Division of Obstetrics and Gynecology, Department of Women’s and Children’s Health, Karolinska University Hospital, Sweden;
  6. Gynecologic Oncology Unit, Zekai Tahir Burak Women’s Health, Education and Research Hospital, Ankara, Turkey;
  7. # Department for Gynecological Oncology, University Clinic of Obstetrics and Gynecology, Skopje, Macedonia.
  1. Address correspondence and reprint requests to Kamil Zalewski, MD, Department of Gynaecologic Oncology, Holycross Cancer Center, 25-734 Kielce, Poland. E-mail: zalewski81{at}


Abstract This is a report from the 20th Meeting of the European Society of Gynaecological Oncology (ESGO) held in Vienna, Austria on November 4 to 7, 2017. The conference offered state-of-the-art educational sessions and oral and poster abstract presentations. The general sessions throughout the meeting focused not only on prevention, screening, diagnosis, treatment, and translational research but also emerging trends, and current innovations in gynecological cancers were discussed. The ESGO-European Society for Radiotherapy and Oncology-European Society of Pathology guidelines on management of cervical cancers were reported for the first time in public. Here, we highlight the key results of the latest trials for gynecological cancers presented for the first time at the ESGO 2017 Meeting and added great value to the congress scientific level.

  • ESGO
  • Gynecological cancer
  • Report
  • Ovarian cancer
  • Endometrial cancer
  • Cervical cancer
  • Vulval cancer

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.